Zusammenfassung
Glaukomdrainageimplantate (GDI) haben eine feste Position in der operativen Behandlung komplizierter, refraktärer Glaukome. Nach der Implantation besteht im Grunde genommen eine permanente Sklerostomie, deren Lumen durch den in der Regel in die Vorderkammer eingelegten Silikonschlauch über lange Zeit offen gehalten wird. Es gibt zwei prinzipiell unterschiedliche GDI: kammerwinkelgestützte und episkleral fixierte. Die kammerwinkelgestützten Systeme drainieren das Kammerwasser entweder in den Schlemm-Kanal, unter die Bindehaut oder in den Zwischenraum zwischen Sklera und Chorioidea. Das Grundprinzip der episkleralen GDI besteht in der Verbindung der Vorderkammer (oder Pars plana) mit einem episkleralen Implantat über einen Silikonschlauch, der mit einer Basisplatte aus Silikon oder Polypropylen verbunden ist. Dadurch wird das Kammerwasser in die Äquatornähe des Bulbus geleitet. Um die Basisplatte von definierter Größe bildet sich nach der Implantation eine Zyste. Diese bewirkt einen Flusswiderstand, der letztendlich den Augeninnendruck bestimmt. GDI (insbesondere die episkleralen Modelle) sind bisher Patienten mit komplizierten, anderweitig erfolglos operierten Glaukomen vorbehalten. Neueren Studien zufolge scheint die Implantation der GDI in früheren Erkrankungsstadien gerechtfertigt.
Der Artikel gibt Auskunft über Prinzipien, Indikationen und Implantationsmethoden sowie Komplikationen von kammerwinkelgestützten und episkleralen GDI.
Abstract
Glaucoma drainage devices (GDDs) have a fixed place in the treatment of complicated refractory glaucoma. By implantation of an episcleral GDD, a permanent open sclerostomy is formed, through which a silicone tube is placed into the anterior chamber (or pars plana). Thus, aqueous humor is drained out of the eye under the Tenon and conjunctiva, leading the fluid to a base plate made from silicone or polypropylene. Placed near the equator of the eye, this base plate leads to the formation of a cyst that renders resistance to fluid transport, ultimately leading to a final drop in intraocular pressure. GDDs have been mainly used in complicated glaucoma cases that had previous unsatisfactory results from conventional glaucoma surgery. Recent studies suggest that the implants can also be used satisfactorily in early stages of glaucoma. Other devices are positioned and fixed in the chamber angle. Here they either drain aqueous humor into the Schlemm’s canal or into the subconjunctival or subchoroidal space. This article gives an overview of the current principles, indications, methods, and possible complications of implantation.
Literatur
Al-Mobarak F, Khan AO (2009) Two year survival of Ahmed valve implantation in the first 2 years of life with and without intraoperative Mitomycin C. Ophthalmology 116:1862–1865
Autrata R, Helmanova I, Oslejskova H et al (2007) Glaucoma drainage implants in the treatment of refractory glaucoma in pediatric patients. Eur J Ophthalmol 17(6):928–937
Ayyala RS, Zurakowski D, Smith JA et al (1998) A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma. Ophthalmology 105:1968–1976
Ayyala RS, Harman LE, Michelini-Norris B et al (1999) Comparison of different biomaterials for glaucoma drainage devices. Arch Ophthalmol 117:233–236
Ayyala RS, Michelini-Norris B, Flores A et al (2000) Comparison of different biomaterials for glaucoma drainage devices: Part 2. Arch Ophthalmol 118:1081–1084
Ayyala RS, Zurakowski D, Monshizadeh R et al (2002) Comparison of double-plate Molteno and Ahmed glaucoma valve in patients with advanced uncontrolled glaucoma. Ophthalmic Surg Lasers Imaging 33:94–101
Cantor L, Burgoyne J, Sanders S et al (1998) The effect of Mitomycin C on Molteno implant surgery: A 1 year randomized, masked prospective study. J Glaucoma 7:240–246
Classen L, Kivelä T, Tarkkanen A (1996) Histopathologic and immunohistochemical analysis of the filtration bleb after unsuccessful glaucoma seton implantation. Am J Ophthalmol 122:205–212
Coleman AL, Hill R, Wilson MR et al (1995) Initial clinical experience with the Ahmed glaucoma valve implant. Am J Ophthalmol 120:23–31
Costa VP, Azuara-Blanco A, Netland PA et al (2004) Efficacy and safety of adjunctive Mitomycin C during Ahmed glaucoma valve implantation: A prospective randomized clinical trial. Ophthalmology 111:1071–1076
Djodeyre MR, Peralta Calvo J, Abelairas Gomez J (2001) Clinical evaluation and risk factors of time to failure of Ahmed glaucoma valve implant in pediatric patients. Ophthalmology 108:614–620
Gedde SJ, Schiffman JC, Feuer WJ et al (2007) Treatment outcomes in the Tube vs. Trabeculectomy study after one year of follow-up. Am J Ophthalmol 143:9–22
Gedde SJ, Schiffman JC, Feuer WJ et al (2009) Three year follow up of the Tube vs. Trabeculectomy Study. Am J Ophthalmol (epub ahead of print)
Heuer DK, Lloyd MA, Abrams DA et al (1992) Which is better? One or two? A randomized clinical trial of single plate vs. double plate Molteno implantation for glaucomas in aphakia and pseudophakia. Ophthalmology 99:1512–1519
Hong CH, Arosemena A, Zurakowski D et al (2005) Glaucoma drainage devices: A systematic literature review and current controversies. Surv Ophthalmol 50:48–60
Hinkle DM, Zurakowski D, Ayyala RS (2007) A comparison of the polypropylene plate Ahmed glaucoma valve to the silicone plate Ahmed glaucoma flexible valve. Eur J Ophthalmol 17:696–701
Huang MC, Netland PA, Coleman AL et al (1999) Intermediate-Term clinical experience with the Ahmed glaucoma valve implant. Am J Ophthalmol 127:27–33
Irak I, Moster MR, Fontanarosa J (2004) Intermediate-term results of Baerveldt tube shunt surgery with Mitomycin C use. Ophthalmic Surg Lasers Imaging 35:189–196
Ishida K, Netland PA, Costa VP et al (2006) Comparison of polypropylene and silicone Ahmed glaucoma valves. Ophthalmology 113:1320–1326
Jong LA de (2009) The Ex-PRESS glaucoma shunt vs. trabeculectomy in open angle glaucoma: a prospective randomized study. Adv Ther 26(3):336–345
Kadri OA, Wilcox MJ (2001) Surface tension controls capsule thickness and collagen orientation in glaucoma shunt devices. Biomed Sci Instrum 37:257–262
Kurnaz E, Kubaloglu A, Yilmaz Y et al (2005) The effect of adjunctive Mitomycin C in Ahmed glaucoma valve implantation. Eur J Ophthalmol 15:27–31
Melamed S, Ben Simon GJ, Goldenfeld M (2009) Efficacy and safety of gold micro shunt implantation to the supracilliary space in patients with glaucoma: a pilot study. Arch Ophthalmol 127(3):264–269
Meyer-ter-Vehn T, Sieprath S, Katzenberger B et al (2006) Contractility as a prerequisite for TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest Ophthalmol Vis Sci 47:4895–4904
Meyer-Ter-Vehn T, Grehn F, Schlunck G (2008) Localization of TGF-beta type II receptor and ED-A fibronectin in normal conjunctiva and failed filtering blebs. Mol Vis 14:136–141
Minckler DS, Francis BA, Hodapp EA et al (2008) Aqueous shunts in glaucoma: A report by the American Academy of Ophthalmology. Ophthalmology 115:1089–1098
Molteno AC (1969) New implant for drainage in glaucoma. A clinical trial. Br J Ophthalmol 53(9):606–615
Molteno AC, Fucik M, Dempster AG et al (2003) Otago glaucoma surgery outcome study: Factors controlling capsule fibrosis around Molteno implants with histopathological correlation. Ophthalmology 110:2198–2206
Nguyen QH (2009) Primary surgical management for refractory glaucoma: Tubes as initial surgery. Curr Opin Ophthalmol 20:122–125
Nouri-Mahdavi K, Caprioli J (2003) Evaluation of the hypertensive phase after insertion of the Ahmed glaucoma valve. Am J Ophthalmol 136:1001–1008
O’Malley Schotthoefer E, Yanovitch TL, Freedman SF (2008) Aqueous drainage device surgery in refractory pediatric glaucomas: I. Long-Term outcomes. J AAPOS 12:33–39
Papadaki TG, Zacharopoulos IP, Pasquale LR et al (2007) Long term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol 144(1):62–69
Pakravan M, Homayoon N, Shahin Y et al (2007) Trabeculectomy with Mitomycin C vs. Ahmed glaucoma implant with Mitomycin C for treatment of pediatric aphakic glaucoma. J Glaucoma 16:631–636
Picht G, Welge-Lussen U, Grehn F et al (2001) Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol 239:199–207
Rachmiel R, Trope GE, Buys YM et al (2008) Ahmed glaucoma valve implantation in uveitic glaucoma vs. open-angle glaucoma patients. Can J Ophthalmol 43(4):462–467
Schulze A (2006) Langzeitverläufe von Glaukomdrainageimplantaten: Vergleich des Molteno Implantates mit dem Ahmed Glaucoma Valve. Promotionsarbeit an der medizinischen Fakultät der Charité, Universitätsmedizin Berlin
Spiegel D, Wetzel W, Haffner DS et al (2007) Initial clinical experience with the trabecular micro bypass-stent in patients with glaucoma. Adv Ther 24(1):161–170
Spiegel D, Garcia-Feijoo J, Garcia-Sanchez J et al (2008) Coexisting primary open-angle glaucoma and cataract: preliminary analysis of treatment by cataract surgery and the iStent trabecular micro-bypass stent. Adv Ther 25(5):453–464
Spiegel D, Wetzel W, Neuhann T et al (2009) Coexisting primary open angle glaucoma and cataract: interim analysis of a trabecular micro-bypass stent and concurrent cataract surgery. Eur J Ophthalmol 19(3):393–399
Tsai JC, Johnson CC, Kammer JA et al (2006) The Ahmed shunt vs. the Baerveldt shunt for refractory glaucoma II: Longer-term outcomes from a single surgeon. Ophthalmology 113:913–917
Wilcox M, Kadri OA (2007) Force and geometry determine structure and function of glaucoma filtration capsules. Ophthalmologica 221:238–243
World Medical Inc. (2004) http://www.ahmedvalve.com, Rancho Cucamonga
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thieme, H. Glaukomdrainageimplantate. Ophthalmologe 106, 1135–1146 (2009). https://doi.org/10.1007/s00347-009-2090-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-009-2090-2